Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | -20.9x - -23.1x | -22.0x |
| Selected Fwd EBIT Multiple | -4.8x - -5.3x | -5.0x |
| Fair Value | $21.19 - $22.56 | $21.87 |
| Upside | 9.5% - 16.5% | 13.0% |
| Benchmarks | Ticker | Full Ticker |
| Labcorp Holdings Inc. | LH | NYSE:LH |
| Quest Diagnostics Incorporated | DGX | NYSE:DGX |
| BioCorRx Inc. | BICX | OTCPK:BICX |
| Regional Health Properties, Inc. | RHEP | OTCPK:RHEP |
| Ethema Health Corporation | GRST | OTCPK:GRST |
| Castle Biosciences, Inc. | CSTL | NasdaqGM:CSTL |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| LH | DGX | BICX | RHEP | GRST | CSTL | ||
| NYSE:LH | NYSE:DGX | OTCPK:BICX | OTCPK:RHEP | OTCPK:GRST | NasdaqGM:CSTL | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | -3.8% | 4.1% | NM- | -50.6% | NM- | 3.4% | |
| 3Y CAGR | -28.9% | -16.2% | NM- | -60.1% | NM- | NM- | |
| Latest Twelve Months | 9.8% | 13.5% | -37.6% | 194.4% | -146.0% | -46.3% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 15.1% | 17.7% | -9591.5% | 1.8% | -60.3% | -31.3% | |
| Prior Fiscal Year | 9.2% | 14.5% | -4194.5% | -5.1% | -10.1% | -30.9% | |
| Latest Fiscal Year | 8.7% | 14.3% | -66829.8% | 0.9% | -22.2% | 2.6% | |
| Latest Twelve Months | 9.2% | 14.4% | -3664.6% | 1.6% | -22.2% | -6.7% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 2.09x | 2.48x | 70.84x | 3.61x | 3.14x | 0.91x | |
| EV / LTM EBITDA | 15.5x | 12.7x | -2.0x | 32.7x | -21.8x | 16.1x | |
| EV / LTM EBIT | 22.8x | 17.2x | -1.9x | 223.6x | -14.2x | -13.6x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -14.2x | 17.2x | 223.6x | ||||
| Historical EV / LTM EBIT | -1629.3x | -24.8x | -4.3x | ||||
| Selected EV / LTM EBIT | -20.9x | -22.0x | -23.1x | ||||
| (x) LTM EBIT | (23) | (23) | (23) | ||||
| (=) Implied Enterprise Value | 482 | 507 | 533 | ||||
| (-) Non-shareholder Claims * | 239 | 239 | 239 | ||||
| (=) Equity Value | 720 | 746 | 771 | ||||
| (/) Shares Outstanding | 29.0 | 29.0 | 29.0 | ||||
| Implied Value Range | 24.84 | 25.71 | 26.58 | ||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 24.84 | 25.71 | 26.58 | 19.36 | |||
| Upside / (Downside) | 28.3% | 32.8% | 37.3% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | LH | DGX | BICX | RHEP | GRST | CSTL | |
| Enterprise Value | 27,904 | 25,818 | 10 | 75 | 19 | 323 | |
| (+) Cash & Short Term Investments | 647 | 319 | 0 | 0 | 0 | 276 | |
| (+) Investments & Other | 160 | 153 | 0 | 0 | 0 | 0 | |
| (-) Debt | (6,603) | (6,384) | (3) | (52) | (17) | (37) | |
| (-) Other Liabilities | (17) | (118) | 0 | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | (0) | (19) | (0) | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 22,092 | 19,788 | 7 | 5 | 2 | 562 | |
| (/) Shares Outstanding | 83.1 | 111.8 | 17.9 | 2.2 | 7,726.3 | 29.0 | |
| Implied Stock Price | 265.85 | 176.96 | 0.41 | 2.05 | 0.00 | 19.36 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 265.85 | 176.96 | 0.41 | 2.05 | 0.00 | 19.36 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |